FDA Investigator Willis L Hicks
Willis L Hicks has conducted inspections on 35 sites in 1 countries as of 06 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
35
Last Inspection Date:
06 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Willis L Hicks:
Aaron J Poloni,
Abby M Miller,
Alan D Grupe,
Alexander M Kay,
Amber M Howell,
Anh Trinh T Nguyen,
Ava M Bowman,
Avery J Dennis,
Belinda E Clifton,
Brenda K Alford,
Brenda L Reihing,
Bruce R Burrell,
Camille Bennett Hoffman,
Ce'nedra M Martin,
Celia L Hutchinstein,
Christina L Norton,
Christopher R Czajka,
Christopher S Genther,
Cynthia L Gorveatt,
David A Quale,
David J Gomes,
Dawn E Barkans,
Deborah A Nebenzahl,
Debra D Devlieger,
Dennis R Hudson,
Devon M Shoop,
Edward D Harris,
Elizabeth A Sheller,
Elizabeth S Howell,
Emanual A Kahsai,
Eric C Milstead,
Gavin W Pierce,
Gerard Pde Leon,
Harmon M Blanch,
Heika R Tait,
Hugh A Grimoldby,
Ian J Thomson,
James E Trabert,
James S Cartwright,
Jason T Lovelady,
Jean C Colon Lopez,
Jeanne M Weishaar,
Jeannie Pradyanata,
Jeannine K Wooten,
Jeffrey J Leclair,
Jeffrey N Gerdes,
Jennifer W Cheng Dobson,
Jessica B Clark,
Jessica L Kocian,
Jinkee Mvila Binayug,
John W Banks,
Jonathan T Little,
Joseph M Hudak,
Julia E Chervoni,
Julian C Hanson,
Julie A Stocklin,
Katharine Chan,
Katherine L Arnold,
Kevin T Gerrity,
Kimberly Jproctor Jones,
Kristina M Phelps,
LCDR Ismael Olvera, IV,
Leon R Marquart,
Lester O Boian,
Leya A Grosch,
Lisa A Bowden,
Lisa K Capron,
Lori J Jennings,
Lori J Silverstein,
Margo C Jones,
Maria Pkelly Doggett, MBA,
Mark E Imsland,
Mark E Moen,
Mark L Collins,
Mark S Crippen,
Marsha L Mccauley,
Michael F Schuette,
Michael J Donovan,
Michael S Hudson,
Michael S Valenzuela,
Mikel T Wright,
Misty L Wallace,
Nancy E Byerly,
Nancy E Doyle,
Narahi J Alvarez Alcazar,
Neil J Traaen,
Paul F Rader,
Paul M Kawamoto,
Peter T Regan,
Phillip J Dugger,
Rebecca A Sletner,
Rebecca T Davis,
Richard A Martin,
Rocco C Black,
Ronald E Gill,
Ronald L Lahti,
S Lori Brown, PhD MPH,
Sandra K Wangen,
Sarah L Clark,
Scott Reynolds,
Scott W Fox,
Shahriar Rahmani,
Shannon J Hall,
Shelagh D Schopen,
Stacy A Schneider,
Stephanie A Slater, MS,
Stephanie J Shaw,
Tara M Pianko,
Thomas C Mclean, CFS,
Vitaliy N Guyvan,
Wilfred J Omoloh,
William A Burkey,
Xiaojun Yan,
Yvonne M Larsen,
Zachary P Wachlarowicz
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more